2022 ESMO Activity Summary
The START Center investigators contributed as authors to 21 posters and abstracts at
this year's ESMO meeting in Paris. Congratulations to the START physician team,
especially first authors Dr. Emiliano Calvo, Dr. Victor Moreno, and Dr. Manish
Sharma, for their contributions to the latest developments in oncology therapeutics.
With five sites and over 500 active and enrolling early-phase studies, the START
Center accelerates drug development, providing new, innovative anti-cancer drugs
across the globe to the patients that need it most.
